Russ Middaugh
Office: B051 Smissman Laboratories Phone: (785)864-5813
FAX: (785)864-5736
Research Interests
The majority of our research focuses in three areas. The first involves
the development of vehicles to deliver polynucleotides for gene therapy.
To this end, we are: (a) exploring the use of physical methods such
as infrared spectroscopy, circular dichroism, fluorescence, light-scattering,
calorimetry and related techniques to characterize viral and nonviral gene
delivery complexes, (b) studying the cellular barriers to vehicle transport
and (c) preparing novel gene delivery systems.
The second area involves studies of proteins that transport across cellular
barriers by currently unknown mechanisms. These efforts involve investigations
of the structure, stability and membrane activity of a wide variety of
proteins of pharmaceutical interest including growth factors and Factor
VIII.
The other major area of interest is vaccines. We are currently
exploring structural aspects of the delivery of both proteins and polynucleotides
as vaccines and the use of adjuvants to enhance immunogenicity in these
systems.
Representative Publications
S. Choosakoonkriang, C. M. Wiethoff, G. S. Koe, J. G. Koe, T. J. Anchordoquy,
and C. R. Middaugh. An infrared spectroscopic study of the effect of hydration
on cationic lipid/DNA complexes. J Pharm Sci 92: 115-30 (2003).
L. A. Kueltzo, J. Osiecki, J. Barker, W. L. Picking, B. Ersoy, W. D. Picking,
and C. R. Middaugh. Structure-Function Analysis of Invasion Plasmid Antigen
C (IpaC) from Shigella flexneri. J Biol Chem 278: 2792-8 (2003).
C. M. Wiethoff, M. L. Gill, G. S. Koe, J. G. Koe, and C. R. Middaugh.
The structural organization of cationic lipid-DNA complexes. J Biol Chem
277: 44980-7 (2002).
D. S. Maclean, Q. Qian, and C. R. Middaugh. Stabilization of proteins
by low molecular weight multi-ions. J Pharm Sci 91: 2220-9 (2002).
D. B. Volkin, G. Sanyal, C. J. Burke, and C. R. Middaugh. Preformulation
studies as an essential guide to formulation development and manufacture
of protein pharmaceuticals. Pharm Biotechnol 14: 1-46 (2002).
C. Y. Huang, S. S. Ma, S. Lee, R. Radhakrishnan, C. S. Braun, S. Choosakoonkriang,
C. M. Wiethoff, B. A. Lobo, and C. R. Middaugh. Enhancements in gene expression
by the choice of plasmid DNA formulations containing neutral polymeric
excipients. J Pharm Sci 91: 1371-81 (2002).
P. O. Souillac, C. R. Middaugh, and J. H. Rytting. Investigation of protein/carbohydrate
interactions in the dried state. 2. Diffuse reflectance FTIR studies.
Int J Pharm 235: 207-18 (2002).
B. A. Lobo, S. A. Rogers, S. Choosakoonkriang, J. G. Smith, G. Koe, and
C. R. Middaugh. Differential scanning calorimetric studies of the thermal
stability of plasmid DNA complexed with cationic lipids and polymers.
J Pharm Sci 91: 454-66 (2002).
S. A. Tatulian, B. Chen, J. Li, S. Negash, C. R. Middaugh, D. J. Bigelow,
and T. C. Squier. The inhibitory action of phospholamban involves stabilization
of alpha-helices within the Ca-ATPase. Biochemistry 41: 741-51 (2002).
P. O. Souillac, H. R. Costantino, C. R. Middaugh, and J. H. Rytting. Investigation
of protein/carbohydrate interactions in the dried state. 1. Calorimetric
studies. J Pharm Sci 91: 206-16 (2002).
Back
to Faculty and Staff
|